576 related articles for article (PubMed ID: 30816797)
1. Recreational use of psychedelics is associated with elevated personality trait openness: Exploration of associations with brain serotonin markers.
Erritzoe D; Smith J; Fisher PM; Carhart-Harris R; Frokjaer VG; Knudsen GM
J Psychopharmacol; 2019 Sep; 33(9):1068-1075. PubMed ID: 30816797
[TBL] [Abstract][Full Text] [Related]
2. In vivo imaging of cerebral serotonin transporter and serotonin(2A) receptor binding in 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy") and hallucinogen users.
Erritzoe D; Frokjaer VG; Holst KK; Christoffersen M; Johansen SS; Svarer C; Madsen J; Rasmussen PM; Ramsøy T; Jernigan TL; Knudsen GM
Arch Gen Psychiatry; 2011 Jun; 68(6):562-76. PubMed ID: 21646575
[TBL] [Abstract][Full Text] [Related]
3. Serotonergic psychedelics and personality: A systematic review of contemporary research.
Bouso JC; Dos Santos RG; Alcázar-Córcoles MÁ; Hallak JEC
Neurosci Biobehav Rev; 2018 Apr; 87():118-132. PubMed ID: 29452127
[TBL] [Abstract][Full Text] [Related]
4. The personality trait openness is related to cerebral 5-HTT levels.
Kalbitzer J; Frokjaer VG; Erritzoe D; Svarer C; Cumming P; Nielsen FA; Hashemi SH; Baaré WF; Madsen J; Hasselbalch SG; Kringelbach ML; Mortensen EL; Knudsen GM
Neuroimage; 2009 Apr; 45(2):280-5. PubMed ID: 19135154
[TBL] [Abstract][Full Text] [Related]
5. Trait Openness and serotonin 2A receptors in healthy volunteers: A positron emission tomography study.
Stenbaek DS; Kristiansen S; Burmester D; Madsen MK; Frokjaer VG; Knudsen GM; Fisher PM
Hum Brain Mapp; 2019 May; 40(7):2117-2124. PubMed ID: 30633430
[TBL] [Abstract][Full Text] [Related]
6. Serotonergic neurotransmission in emotional processing: New evidence from long-term recreational poly-drug ecstasy use.
Laursen HR; Henningsson S; Macoveanu J; Jernigan TL; Siebner HR; Holst KK; Skimminge A; Knudsen GM; Ramsoy TZ; Erritzoe D
J Psychopharmacol; 2016 Dec; 30(12):1296-1304. PubMed ID: 27599522
[TBL] [Abstract][Full Text] [Related]
7. Long-term use of psychedelic drugs is associated with differences in brain structure and personality in humans.
Bouso JC; Palhano-Fontes F; Rodríguez-Fornells A; Ribeiro S; Sanches R; Crippa JA; Hallak JE; de Araujo DB; Riba J
Eur Neuropsychopharmacol; 2015 Apr; 25(4):483-92. PubMed ID: 25637267
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic effect of increased openness: Investigating mechanism of action in MDMA-assisted psychotherapy.
Wagner MT; Mithoefer MC; Mithoefer AT; MacAulay RK; Jerome L; Yazar-Klosinski B; Doblin R
J Psychopharmacol; 2017 Aug; 31(8):967-974. PubMed ID: 28635375
[TBL] [Abstract][Full Text] [Related]
9. Psychedelics, Personality and Political Perspectives.
Nour MM; Evans L; Carhart-Harris RL
J Psychoactive Drugs; 2017; 49(3):182-191. PubMed ID: 28443703
[TBL] [Abstract][Full Text] [Related]
10. Evidence for chronically altered serotonin function in the cerebral cortex of female 3,4-methylenedioxymethamphetamine polydrug users.
Di Iorio CR; Watkins TJ; Dietrich MS; Cao A; Blackford JU; Rogers B; Ansari MS; Baldwin RM; Li R; Kessler RM; Salomon RM; Benningfield M; Cowan RL
Arch Gen Psychiatry; 2012 Apr; 69(4):399-409. PubMed ID: 22147810
[TBL] [Abstract][Full Text] [Related]
11. Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[(11)C]DASB and structural brain imaging study.
Kish SJ; Lerch J; Furukawa Y; Tong J; McCluskey T; Wilkins D; Houle S; Meyer J; Mundo E; Wilson AA; Rusjan PM; Saint-Cyr JA; Guttman M; Collins DL; Shapiro C; Warsh JJ; Boileau I
Brain; 2010 Jun; 133(Pt 6):1779-97. PubMed ID: 20483717
[TBL] [Abstract][Full Text] [Related]
12. Personality traits explain the relationship between psychedelic use and less depression in a comparative study.
Sjöström DK; Claesdotter-Knutsson E; Kajonius PJ
Sci Rep; 2024 May; 14(1):10195. PubMed ID: 38702496
[TBL] [Abstract][Full Text] [Related]
13. Brain serotonin transporter binding in former users of MDMA ('ecstasy').
Selvaraj S; Hoshi R; Bhagwagar Z; Murthy NV; Hinz R; Cowen P; Curran HV; Grasby P
Br J Psychiatry; 2009 Apr; 194(4):355-9. PubMed ID: 19336788
[TBL] [Abstract][Full Text] [Related]
14. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
Thomasius R; Zapletalova P; Petersen K; Buchert R; Andresen B; Wartberg L; Nebeling B; Schmoldt A
J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
[TBL] [Abstract][Full Text] [Related]
15. The Psychedelic Personality: Personality Structure and Associations in a Sample of Psychedelics Users.
Johnstad PG
J Psychoactive Drugs; 2021; 53(2):97-103. PubMed ID: 33252034
[TBL] [Abstract][Full Text] [Related]
16. Neurovascular Uncoupling: Multimodal Imaging Delineates the Acute Effects of 3,4-Methylenedioxymethamphetamine.
Ionescu TM; Amend M; Watabe T; Hatazawa J; Maurer A; Reischl G; Pichler BJ; Wehrl HF; Herfert K
J Nucl Med; 2023 Mar; 64(3):466-471. PubMed ID: 36175138
[TBL] [Abstract][Full Text] [Related]
17. In abstinent MDMA users the cortisol awakening response is off-set but associated with prefrontal serotonin transporter binding as in non-users.
Frokjaer VG; Erritzoe D; Holst KK; Madsen KS; Fisher PM; Madsen J; Svarer C; Knudsen GM
Int J Neuropsychopharmacol; 2014 Aug; 17(8):1119-28. PubMed ID: 24524290
[TBL] [Abstract][Full Text] [Related]
18. Illicit use of LSD or psilocybin, but not MDMA or nonpsychedelic drugs, is associated with mystical experiences in a dose-dependent manner.
Lyvers M; Meester M
J Psychoactive Drugs; 2012; 44(5):410-7. PubMed ID: 23457892
[TBL] [Abstract][Full Text] [Related]
19. Serotonergic function after (+/-)3,4-methylene-dioxymethamphetamine ('Ecstasy') in humans.
Gerra G; Zaimovic A; Giucastro G; Maestri D; Monica C; Sartori R; Caccavari R; Delsignore R
Int Clin Psychopharmacol; 1998 Jan; 13(1):1-9. PubMed ID: 9988361
[TBL] [Abstract][Full Text] [Related]
20. Long-term neuronal damage and recovery after a single dose of MDMA: expression and distribution of serotonin transporter in the rat brain.
Kirilly E
Neuropsychopharmacol Hung; 2010 Sep; 12(3):413-23. PubMed ID: 20962361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
